SGHT
Sight Sciences, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$8.02
−0.74%Next report
Analyst consensus
- Next report date
- Nov 5, 2026
- EPS estimate
- -$0.13
- Revenue estimate
- $23.5M
Latest reported
- Last report date
- Aug 5, 2026
- EPS actual
- -$0.08
- EPS estimate
- -$0.18
- Revenue actual
- $23.4M
- Revenue estimate
- $21.6M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 10
- EPS misses (12Q)
- 2
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +39.3%
- Revenue beats (12Q)
- 7
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $7.00
- PT range
- $6.00 – $8.00
- Analysts
- 2
1 Buy1 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 5, 2026 | -$0.18 | -$0.08 | Beat 56.36% | $23.4M |
| May 6, 2026 | -$0.19 | -$0.16 | Beat 15.79% | $19.7M |
| Mar 4, 2026 | -$0.15 | -$0.08 | Beat 46.67% | $20.4M |
| Nov 6, 2025 | -$0.26 | -$0.16 | Beat 38.46% | $19.9M |
| Aug 7, 2025 | -$0.25 | -$0.23 | Beat 8.00% | $19.6M |
| May 8, 2025 | -$0.29 | -$0.28 | Beat 3.45% | $17.5M |
| Mar 5, 2025 | -$0.22 | -$0.23 | Miss -4.55% | $19.1M |
| Nov 7, 2024 | -$0.23 | -$0.22 | Beat 4.35% | $20.2M |
| Aug 1, 2024 | -$0.31 | -$0.25 | Beat 19.35% | $21.4M |
| May 2, 2024 | -$0.29 | -$0.33 | Miss -13.79% | $19.3M |
| Mar 7, 2024 | -$0.35 | -$0.22 | Beat 37.14% | $18.8M |
| Aug 3, 2023 | -$0.35 | -$0.30 | Beat 14.29% | $23.5M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 5, 2026